Methods for treating Dutch elm disease
AssigneeResearch and Development Institute, Inc. at Montana State University
InventorGary A. Strobel
Life of this patent
Estimating the term…
Abstract
A method for treating Dutch elm disease by treatment of an elm tree with a microorganism comprising P. syringae or equivalent. The method includes the step of applying the microorganism to an elm tree early in the growing seaons and wherein no more than 10% of the crown of the tree is infected with the disease.
Claims16
A method for treating Dutch elm disease comprising applying a microorganism comprising a strain of P. syringae to an elm tree in a Dutch elm disease-controlling amount;
- said strain of P. syringae being at least as active against Dutch elm disease as P. syringae NRRL B-12050;
- said microorganism being applied early in the growing season when the sap is active, and wherein the microorganism is applied to an elm tree having no more than about 10% of its crown showing disease symptoms.
A high molecular weight antibiotic useful in the treatment of Dutch elm disease, said antibiotic produced by incubating P. syringae NRRL B-12050 at about 25-28.degree. C. in an about 1.5-2.5% potato dextrose broth adjusted to a final concentration of about 0.5-3% glucose, for about two to four days;
- mixing a precipitating agent with the incubated broth in an amount sufficient to precipitate very high molecular weight substances;
- separating the precipitate and the liquid phase from each other;
- evaporating the liquid phase to dryness, thereby leaving a residue;
- chromatographing the residue on a column capable of separating in the void volume of eluate, substances having a molecular weight of at least about 1,800 from low molecular weight substances;
- and recovering said high molecular weight antibiotic from said void volume of eluate;
- wherein the processing steps are carried out at a temperature below about 50.degree. C.;
- said antibiotic being characterized by having a molecular weight of between about 1,800 and 20,000, and consisting of amino acids including arginine, unknown amino acid, aspartic acid, threonine, serine, glutamine, glycine, alanine, valine, methionine, isoleucine, leucine, tyrosine, and phenylalanine;
- the antibiotic being acetone soluble, fairly water soluble, heat stable, sensitive to base above pH of about 7.5 to 8, acid stable at pH no lower than about 4 or 5, insensitive to proteinase K, and refractory to leucine aminopeptidase inactivation;
- and said antibiotic being retained during ultrafiltration by a PM-10 membrane and not entering a native 15% polyacrylamide gel.
A process for obtaining the high molecular weight antibiotic of claim 15 from P. syringae NRRL B-12050, said process comprising incubating the P. syringae at about 25.degree.-28.degree. C. in an about 1.5-2.5% potato dextrose broth adjusted to a final concentration of about 0.5-3% glucose, for about two to four days;
- mixing a precipitating agent with the incubated broth in an amount sufficient to precipitate very high molecular weight substances, separating the precipitate and the liquid phase from each other;
- evaporating the liquid phase to dryness, thereby leaving a residue;
- chromatographing the residue on a column capable of separating in the void volume of eluate, substances having a molecular weight of at least about 1,800 from low molecular weight substances;
- and recovering said high molecular weight antibiotic from said void volume of eluate;
- wherein the processing steps are carried out at a temperature below about 50.degree. C.
Dependencies are inferred from the claim text.